Brett Wall
Chief Executive Officer bij Medina Medical, Inc.
Vermogen: 3 M $ op 31-03-2024
Profiel
Brett Wall is currently the Chief Executive Officer at Medina Medical, Inc. and the President-Neurovascular & International at Covidien Unlimited Co. He previously worked as the Director-Cardiovascular Marketing at Boston Scientific Corp.
and as the Vice President-Sales & Marketing at Micro Therapeutics, Inc. from 2001 to 2009.
He also worked as the President-International & Senior Vice President at ev3, Inc. Mr. Wall received his undergraduate degree from the University of Nebraska.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
MEDTRONIC PLC
0.00% | 19-12-2023 | 28 910 ( 0.00% ) | 3 M $ | 31-03-2024 |
Actieve functies van Brett Wall
Bedrijven | Functie | Begin |
---|---|---|
Covidien Unlimited Co.
Covidien Unlimited Co. Medical SpecialtiesHealth Technology Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
Medina Medical, Inc.
Medina Medical, Inc. Medical SpecialtiesHealth Technology Medina Medical, Inc. operates as a neurovascular company. The firm provides minimally-invasive devices for the treatment of brain aneurysms and stroke. The company was founded by Maria Aboytes and Kimberly Vogel in 2010 and is headquartered in Menlo Park, CA. | Chief Executive Officer | - |
Eerdere bekende functies van Brett Wall
Bedrijven | Functie | Einde |
---|---|---|
Micro Therapeutics, Inc.
Micro Therapeutics, Inc. Medical SpecialtiesHealth Technology Micro Therapeutics, Inc. develops, manufactures and markets invasive medical devices for the diagnosis and treatment of vascular diseases. Its products include infusion catheters, ballon catheters, delivery catheters, guide wires, infusion wires, and thrombolytic brushes. The company was founded in 1993 and is headquartered in Irvine, CA | Sales & Marketing | 01-10-2009 |
BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Corporate Officer/Principal | - |
Opleiding van Brett Wall
University of Nebraska | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Micro Therapeutics, Inc.
Micro Therapeutics, Inc. Medical SpecialtiesHealth Technology Micro Therapeutics, Inc. develops, manufactures and markets invasive medical devices for the diagnosis and treatment of vascular diseases. Its products include infusion catheters, ballon catheters, delivery catheters, guide wires, infusion wires, and thrombolytic brushes. The company was founded in 1993 and is headquartered in Irvine, CA | Health Technology |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |
Medina Medical, Inc.
Medina Medical, Inc. Medical SpecialtiesHealth Technology Medina Medical, Inc. operates as a neurovascular company. The firm provides minimally-invasive devices for the treatment of brain aneurysms and stroke. The company was founded by Maria Aboytes and Kimberly Vogel in 2010 and is headquartered in Menlo Park, CA. | Health Technology |
Covidien Unlimited Co.
Covidien Unlimited Co. Medical SpecialtiesHealth Technology Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland. | Health Technology |